Print ISSN: 2582-4147
Online ISSN: 2582-421X
CODEN : IJOABK
IP Journal of Otorhinolaryngology and Allied Science (JOAS) open access, peer-reviewed quarterly journal publishing since 2018 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Case Report
Author Details :
Volume : 4, Issue : 1, Year : 2021
Article Page : 33-35
https://doi.org/10.18231/j.ijoas.2021.007
Abstract
Active squamosal chronic otitis media is a challenging disease for both patients and doctors. Traditionally performing bilateral mastoidectomy has been feared with a dreadful complication like bilateral sensorineural hearing loss, facial palsy, cerebrospinal fluid leak or retrograde thrombophlebitis and thus was reserved for patients who were chronic ill with bilateral active squamosal disease and couldn’t wait for two staged procedure, or those who want to avoid the hassle of two admissions and operations and
those who couldn’t afford two surgeries. In our patient, with single stage bilateral surgery there was no complication and the patient recovered completely. So, we suggest that bilateral mastoidectomies can be performed in squamosal chronic otitis media if needed.
Keywords: Cholesteatoma, Middle ear, Otologic surgical procedures, Mastoidectomies, Facial nerve palsy.
How to cite : Singh A , Gupta M , Simultaneous bilateral mastoidectomy: A case report. J Otorhinolaryngol Allied Sci 2021;4(1):33-35
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.